Clinical Trial Update: Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluating the combination of Calcitriol and Dexamethasone in patients with myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Calcitriol (calcitriol)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University of Pittsburgh | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED